Hematologia Geral
[Preprint] Heparina para pacientes com Covid-19 moderada – “Em pacientes com Covid-19 moderada e D-dímero elevado, a terapia com heparina não reduziu significativamente o desfecho primário, mas reduziu as chances de morte em 28 dias de doença.”
12 Jul, 2021 | 11:41hHeparin for Moderately Ill Patients with Covid-19 – medRxiv
Relacionado: RCT: In patients hospitalized with Covid-19 with elevated D-Dimer, a full-dose anticoagulation strategy based on rivaroxaban (full-dose heparins in unstable patients) + rivaroxaban to day 30 was not better than prophylactic anticoagulation and increased bleeding risk. E [Preprint] Practice Changing RCT: Therapeutic-dose anticoagulation with heparin (LMWH or unfractionated heparin) improves outcomes in non-critically ill patients with Covid-19 – the superiority of therapeutic-dose anticoagulation was seen in both high and low D-dimer groups. E [Preprint] RCT: Full-dose/therapeutic anticoagulation provides no benefit in critically ill patients with Covid-19
Comentário no Twitter (fio – clique para saber mais)
🚨Final results of the RAPID trial now pub'd @medrxivpreprint 🚨 RAPID was an open-label trial that randomly assigned hospitalized ward patients with COVID-19 and elevated D-dimer levels to therapeutic or prophylactic heparin. 🧵 1/10 https://t.co/oxiyXQAPeK pic.twitter.com/V2GtruEyM2
— Michelle Sholzberg (@sholzberg) July 9, 2021
Podcast | Sangramento menstrual intenso, anticoagulação e coagulopatia em pacientes que menstruam.
9 Jul, 2021 | 15:46hSérie de casos | Plasmaférese em 3 pacientes com trombocitopenia trombótica imune induzida por vacina.
8 Jul, 2021 | 09:56h
Comentário no Twitter
Three patients with severe manifestations of VITT after #COVID19 vaccination had poor response to initial therapy with anticoagulants and intravenous immune globulin. Their condition improved after therapeutic plasma exchange was initiated.
— NEJM (@NEJM) July 7, 2021
Diretriz sobre a abordagem perioperatória de pacientes com anemia falciforme.
8 Jul, 2021 | 09:36hGuideline on the peri-operative management of patients with sickle cell disease – Anaesthesia
M-A | Plasma convalescente é seguro, mas não melhora os desfechos no tratamento da COVID-19.
7 Jul, 2021 | 08:07hTrombocitopenia trombótica imune induzida por vacina (vaccine-induced immune thrombotic thrombocytopenia – VITT) – Uma nova entidade clinicopatológica com apresentações clínicas heterogêneas.
2 Jul, 2021 | 11:17hComentário: Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection – MedicalXpress
Embolia pulmonar em pacientes com COVID-19: incidência, fatores de risco, características clínicas e desfechos.
30 Jun, 2021 | 10:43hPreocupado com as últimas notícias sobra a AstraZeneca? Estes 3 gráficos ajudam a compreender o risco – “Na Austrália, 2 pessoas morreram de trombose com trombocitopenia após 3,8 milhões de doses da vacina da AstraZeneca terem sido aplicadas.”
21 Jun, 2021 | 10:58hRevisão | Tromboembolismo venoso e arterial em pacientes com câncer.
16 Jun, 2021 | 10:49hResumo: Venous and Arterial Thromboembolism in Patients With Cancer – American College of Cardiology